Adaptive Recruitment Curve Analysis Using Bayesian Modeling
Columbia University · with National Institute of Neurological Disorders and Stroke (NINDS) · NCT07561372
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 14
- US sites recruiting
- 1
- Study start
- September 1, 2026
- Record last updated
- August 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to better understand how electrical or magnetic stimulation affect the nervous system by optimizing the way researchers measure muscle responses. The relationship between stimulation intensity and muscle response is described by "neural recruitment curves," which are critical for monitoring the state of the nervous system during therapies like transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS).
This study tests a new, real-time computational approach based on our previously developed methods (Hierarchical Bayesian models) to estimate these recruitment curves more efficiently. The primary goal is to use this model to dynamically guide the experiment, automatically selecting the optimal stimulation intensities to test.
The investigators hypothesize that this optimized approach will accurately estimate the entire recruitment curve, or specific targets components of it like the motor threshold, using significantly fewer samples than standard methods. By reducing the number of measurements required, this approach aims to decrease experimental time and minimize participant burden, making future TMS and SCS therapies and experiments more feasible and efficient.
Being studied: Algorithm: Uniform Sampling; Algorithm: hbMEP-adaptive algorithm (version 1); Algorithm: hbMEP-adaptive algorithm (version 2); ML-PEST; MagPro X100 Transcranial Magnetic Stimulation; Digitimer DS8R Transcutaneous Electrical stimulation
Conditions: Modeling of Recruitment Curves
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy adult volunteers aged 18 years and older.
- Able to understand study procedures and provide written informed consent.
Exclusion Criteria
- 1. History of adverse reaction to Transcranial Magnetic Stimulation (TMS) or non-invasive neurostimulation.
- 2. History of seizures, epilepsy, or family history of epilepsy.
- 3. History of stroke, brain injury, or illness causing brain injury.
- 4. History of head injury or neurosurgery.
- 5. History of neurological diseases, or central nervous system lesions.
- 6. Presence of metallic implants or foreign bodies in the head (outside of dental work/fillings).
- 7. Presence of implanted electronic or medical devices (e.g., cardiac pacemakers, medical pumps, implanted stimulators).
- 8. Current pregnancy or possibility of pregnancy.
- 9. Currently taking medications that alter cortical excitability or lower seizure threshold.
Recruiting US locations
Columbia University Irving Medical Center
New York, NY 10032
Site contact: James R McIntosh, PhD · 9294352335 · jrm2263@cumc.columbia.edu
Study contacts (from the official record)
- James R McIntosh, PhD · +19294352335 · jrm2263@cumc.columbia.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1